Automated Accounts Payable provider Glantus Holdings raises 14M and successfully floats on AIM. Watch the full video here.
It certainly was not an amount that meant it could be fast-tracked as 'insurance' insurance that we may now well be in need of and I'm sure the Gov was given an amount required and I doubt it would have been crippling probably around 10 mil or so to hire more staff etc to speed progress... anyways....
It is why though I'm happy BioNTech are winning because they are also a Uni spin out with science at its core...I'm sure they will spend their new riches wisely...
So now the lockdown release is at risk due to surprise surprise VOC's could never of seen that coming!.... You would think a variant proof vax would have been heavily backed from the beginning the gov has given the Notts team a paltry amount ...what for being the wrong university or something.
That Sally is not on SCIB1 anymore is telling that she is busy elsewhere.... good that we now have such a strong team where duties can be spread I'm sure Covidity trial is for scancell a huge task and we should always remember even with redmile/vulpes funds scancell compared to most others is on a shoestring to have 3 trials up and running is going to be a massive achievement .... BTW I've had to give the Astazeneca jab a yellow card... phew 6 hours after having it my blood turned to Nandos hottest sauce and I got into a ring with Mike Tyson in his prime and called him a clown!... Yeah rough pnly just getting over it and I'm far from the only one really made me appreciate 'tolerability' and not knocking its effectiveness or wish to put anyone off because clearly, it is a potent vax but the idea of having to go through that via boosters every so often... phew.... now if there were a jab that offered on one dose 3 years maybe 5 better broader protection.... yes acceptable.. It'll be another reason BioNTechs is winning the race with far fewer yellow cards... I'd hope Covidity falls in with those mRNA ones for yellow cards.... seem to remember SCIB1 trial had maybe 90% of patients reporting side effects none of those adverse and pretty much all and quite understandable Ichor related... another reason despite their tweet army Inovio are out of the race already.
Don't worry Lindy no doubts will be tuning in to listen to this and take note at the CIMT event ...
'As part of a dedicated COVID-19 - immuno-oncology cross-talk session, Ugur Sahin of BioNTech will deliver the keynote on the scientific journey of developing an mRNA coronavirus vaccine in 10 months.'
Thanks boom.... scancell do seem to like this event....
'2021 Scientific Planning Committee
Oslo University Hospital, Oslo/Norway
Sine Reker Hadrup
Denmark Technical University, Copenhagen/Denmark
Leiden University Medical Center, Leiden/The Netherlands
TRON-Translational Oncology, Mainz/Germany; Head of CIMT Management Board
TRON-Translational Oncology, Mainz/Germany; CIMT Scientific Secretary
Hopefully, we will hear more about what these new research insights mean, scancell team science never sleeps.
Well done WTP no idea what your holding plan there is but for a longtime I wondered how can their mcap be so big not now I don't and reckon they could double it.... what a great potential scancell partner they could come to be ... certainly they are the winners for now out of the vax race.
Variants vid for kids and err me! :)
Got all AstraZenca'd up this morning so far so good.... And a big shout out to all this great nations volunteers what a slick operation they have helped pull off.... We should cherish our NHS
Going from my speculating Sunday.... the Notts delivery could offer a potential another route for mRNA vax delivery too... delivery there currently using lipids which have issues around manufacture and patents plus not too sure if they will with repeated use cause adverse effects... that is an ongoing experiment that will play out as people have more and more shots... there is a possibility the body can build up a resistance produce an immune response against the lipids
So the Notts vax is super novel in so many ways that could have an influence beyond scancell
The truth is it was the other way round mRNA vaxs originally cancer vaxs just like ours ... another tick for the CEPI box I would say seeing as how those cancer vax platforms have turned out to be the best for beating covid too...
you will find your answer there ... they have 2 preclincal vaxs already of course they must do there due diligence before committing funds for scancell that ImmunoBody has been through a trial must be a plus...of course that is fi we are in negotiations with them and my feeling is we are and they started about the time TGs CEPI Twitter storm ended which was pre their $200 million call... so it could well be like VBI ph1/2 initiated and CEPI funding news all at once....... though like others have said its no guarantee and till we know we don't certainly their $200 mill call ends the end of this month but I don't think that means that's when they decide they can do that any time they like before and after.... I'd like to think if it is the route chosen scancell are in with a good shout.
When the potential size of your asset keeps growing at the same time as demand increases.
' Demand for lithium, for example, is expected to grow 70 times over the next couple decades. But the supply from existing lithium mines and projects under construction can only meet about half the projected demand this decade.
“This mismatch is something that worries us,” Fatih Birol, the executive director of the IEA, said at a press conference today. “Our numbers show that the critical minerals are not a sideshow in our journey to reach climate goals. It’s a part of the main event.”
Batteries for electric vehicles (EVs) and renewable energy storage are the biggest factor driving the potential mineral shortage. An EV requires six times more mineral resources than a car that runs on fossil fuels. Cobalt, nickel, graphite, and manganese are essential for batteries, too.'
'the IEA expects a shortfall unless new mineral deposits are tapped. Production of new critical minerals isn’t ramping up fast enough because investors aren’t convinced that world leaders are fully committed to their climate goals, according to Birol.
“If they get from the governments unmistakable signals that clean energy technologies are the technologies of tomorrow, then I believe this investment will flow,” he says. Until then, limited supplies of critical minerals will loom large over any global action on climate change.'
So VBI story seems to be they got $56 million CAN in August last year from the Canadian Gov to progress their covid variants of concern vax then they announced March 9th this year initiation of ph1/2 trial ... and then the next day March 10th CEPI announcement of $33 million funding and collaboration ....not sure if anyone has actually been dosed yet though.
I know it's mostly me just waffling to myself but I'm not up to much else at the moment so :)....
What I ought to do is write up something around all the listed covid vax plays....
for instance, VBI from that article, went from $0.78 in March last year which is when the CEPI funding came in and spiked up to $6.17 by July and have since been dropping down to where they are today at $2.78 a current mcap of $706 million
And where I see Covidity fitting....
'VBI is now leading a new contingent of companies: smaller biotechs that are focused on creating a pan-coronavirus vaccine that can be effective against all variants of Covid-19, as well as coronaviruses that might have pandemic potential in the future. This is a contrast to the “vanguard 5,” whose next-generation vaccines are currently more geared towards booster shots and specific new variants. In March VBI entered a $33 million partnership with the Coalition for Epidemic Preparedness Innovations, also known as CEPI, to develop a pan-coronavirus vaccine that can protect against new Covid-19 variants and other coronaviruses. Clinical trials will start in the second half of this year.
Half a dozen other companies are charting the same course, hoping to be the winner in this second Covid-19 vaccine race. A vaccine that could protect against all variants of Covid-19 could quickly replace the current vaccines, some of which have shown diminished efficacy against variants first discovered in South Africa and Brazil. But the real prize would be a vaccine that could protect against all betacoronaviruses, the family of viruses that also birthed SARS, MERS and varieties of the common cold. “We’ve seen coronaviruses mutate to be humanly transmissible about every 9 years,” Baxter says. “We need to figure out just how wide we can make those goalposts to cover any novel or mutant strain.” '
And yes CEPI route seems about the right fit....
BTW... yes the patent waiver is a negative however what it really means is the world needs more vaccines!
We know the mRNA ones are not going to be copied during the life of this pandemic... it is just practically impossible and I'd say Covidity falls in there too plus ours in theory will if it ever does arrive post pandemic as in it will be a booster variant protection vax.....
The pressure is now on and I'd say it is on those already winning the race to get more vaccines around the world well there are limits on how many mRNA ones you can practically make.
Again all just thoughts I expect BioNTech is super busy and not looking in that direction however the US GOV has made a signal and if you read what the wrote they have also said they will make the vax components more globally available too as up to now they have been protecting those for US first use.....
Could all play interestingly
BioNTech expects the C19 pandemic to end by the middle of next year its vax playing a key part in that... then it would be down to testing, tracking, vax boosters and vaxs against variants or more attractively second-gen broader and longer protecting vaxs (Covidity)...BioNTech expects their vaxs to be mixed with other vaxs in dosing...
'Mixing and matching of different types of vaccines, including combining shots based on messenger RNA technology such as BioNTech's with the so-called viral vector vaccines like that of AstraZeneca PLC, could be necessary to end the pandemic, said Dr. Tureci, BioNTech's chief medical officer.
"The more vaccines we have available, the better…We can obviously mix and match them in principle," she said. "Because at the end of the day, we want to achieve herd immunity. We want to achieve as many vaccinated people as possible."'
BioNTech have gotten themselves into a powerful global position being able to manufacture and distribute their expensive short shelf life with storage issues (but very effective and much desired) vax and they are also moving into China plus they now have significant profit funds too... yes they are already working on vaxs against variants but could it be in their interest to now get involved away from Pfizer the wolf in partnering a 'universal covid vax'... one developed by a friend no less! :)
BTW doubt they are concerned about patent waiver its vaccine requires 280 different materials and components that are sourced from 19 countries around the world and put together by elite artists!
Anyways I expect it all to be explained in tomorrows RNS..... As probably Mondays are still odds on (Ruck)
a worthwhile read: